Evidence-based evaluation of study results of symptomatic glucosamine therapy;Evidenzbasierte bewertung der symptomatischen therapie von glucosamin

Zeitschrift fur Rheumatologie

Volumn 64, Issue 7, 2005, Pages 456-466

  Reiter, S ^a  

^a Bundesinstitut fur Arzneimittel und Medizinproducte   (Germany)

Author keywords

Clinical studies; Glucosamine; Knee osteoarthritis; Meta analysis; Symptomatic therapy

Indexed keywords

GLUCOSAMINE;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; KNEE OSTEOARTHRITIS; META ANALYSIS; SYSTEMATIC REVIEW;

ANALGESICS, NON-NARCOTIC; ANTIRHEUMATIC AGENTS; ARTHRALGIA; CLINICAL TRIALS; COMORBIDITY; EVIDENCE-BASED MEDICINE; GLUCOSAMINE; HUMANS; INCIDENCE; OSTEOARTHRITIS; PALLIATIVE CARE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 27144505493     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-005-0777-6     Document Type: Article

References (32)

1. BGA (1988) Bekanntmachung über die Zulassung und Registrierung von Arzneimitteln (Aufbereitungsmonographien für den humanmedizinischen Bereich: D-Glucosamin. BAnz. Nr. 35718
2. BGA (1992) Bekanntmachung über die Zulassung und Registrierung von Arzneimitteln (Aufbereitungsmonographien für den humanmedizinischen Bereich): D-Glucosamin. BAnz. Nr. 104:4540
3. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drung therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15(12):1833-1840
4. Cibere J, Kopec JA, Thorne A et al (2004) Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum 51(5):738-745
5. Cohen J (1977) Stastical power analysis for the behavioral sciences. Acamic Press, New York
6. Committee for Proprietary Medicinal Products (1998) Points to consider on clinical investigation of medicinal products used in the treatment of OA (CPMP/EWP/784/97)
7. Drovanti A et al (1980) Therapeutic activity of oral glucosamine sulfate in osteoarthritis: a placebo-controlled, double-blind investigation. Clin Ther 3:266-272
8. Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N (2000) Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessment in patients with osteoarthritis. J Rheumatol 27(11):2635-2641
9. Houpt JB, McMillan R, Paget-Dellio D, Russell A, Gahunia HK (1998) Effect of glucosamine hydrochloride (GHcl) in the treatment of pain of osteoarthritis of the knee. J Rheumatol 25(Suppl 52):8
10. Houpt JB, McMillar R (1999) Effect of glucosamin hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 26(11):2423-2430
11. Hughes R, Carr (2002) A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgestic in osteoarthritis of the knee. Rheumatology 41:279-284
12. Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1-12
13. Jordan KM, Arden NK, Doherty M et al (2003) EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies including Therapeutic Trials (ESCISIT) Ann Rheum Dis 62:1145-2255
14. Lequèsne MG (1997) The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 24:779-781
15. McAlindon TE et al (2000) Glucosamine and chondroitin for treatment of osteoarthritis. A systematic quality assessment and meta-analysis. JAMA 283(11):1469-1474
16. McAlindon T, Formica M, LaValley M, Lehmer M, Kabbara K (2004) Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial. Am J Med 117(9):643-649
17. Noack W (1994) Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis and Cartilage 2:51-59
18. Pavelka K et al (2002) Glucosamine sulfate use and delay of progression of knee osteoarthritis. A 3-year randomized, placebo-controlled, double-blind study. Arch Intern Med 162:2113-2123
19. Points to Consider on Application with 1. Meta-Analyses; 2. One Pivotal Study (CPMP/EWP/2330/99) (http://www.emea.eu.int/)
20. Pujalte JM et al (1980) Double-blind-clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Curr med Res Opin 7:110-114
21. Recommendations from a task force of the Osteoarthritis Research Society (1996) Design and conduct of clinical trials in patients with osteoarthritis. Osteoarthritis and Cartilage 4:217-243
22. Reginster J et al (2001) Long-term effects of glucosamine sulfate on osteoarthritis progression. a randomised, placebo-controlled clinical trial. The Lancet 357:251-256
23. Richy F et al (2003) Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis. A comprehensive meta-analysis. Archives of Internal Medicine 163:1514-1522
24. Rindone JP (2000) Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. Western Journal of Medicine 17:91-94
25. Rovati LC (1997) The clinical profile of glucosamine sulfate as a selective symptom modifying drug in osteoarthritis: current data and perspectives. Osteoarthritis Cartilage 5(Supp A):72
26. Todd KH, Funk JP (1996) The minimum clinically important difference in physician-assigned visual analog pain scores. Acad Emerg Med 3(2):142-146
27. Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC (2004) Glucosamine therapy for treating osteoarthritis (Cochrane Review). In: The Cochrane Library
28. Towheed TE, Maxwell L, Anastassiades TP et al (2005) Glucosamine therapy for treating osteoarthritis (Cochrane Review). In: The Cochrane Library
29. Tubach F, Ravaud P, Baron G et al (2005) Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 64(1):29-33
30. Usha PR, Naidu MUR (2004) Randomized, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clinical Drug Investigation 24(6):353-563
31. WHO (2005) Pharmaceutical Newsletter No. 1, p 4
32. Zenk JL, Helmer TR, Kuskowski MA (2002) The effects of milk protein concentrate on the symptoms of osteoarthritis in adults: an exploratory, randomized, double-blind, placebo-controlled trial. Current Therapeutic Research 63(7):430-442